Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
DOI
PMC
 |
Open Access Hybrid |
|
as soon as is submitted to ZB.
AlphaMissense prediction for the evaluation of missense variants in the diagnostic setting of neuromuscular disorders.
J. Neuromuscul. Dis., DOI: 10.1177/22143602251370957:22143602251370957 (2025)
Next-generation sequencing has improved diagnostic outcomes for neuromuscular disorders, but interpreting rare missense variants remains challenging. We evaluated AlphaMissense, a recently developed machine learning tool, for predicting missense variant pathogenicity, using 45 (likely) pathogenic variants and 21 variants of uncertain significance from 58 deeply phenotyped patients. AlphaMissense predicted 69% of pathogenic variants correctly, but also classified 62% of variants of uncertain significance as pathogenic. Median AlphaMissense scores were not significantly different between pathogenic and uncertain variants. Overall, AlphaMissense accurately predicted the pathogenicity of most missense variants, but may be limited in certain functional contexts, highlighting the need for disease-specific interpretation approaches.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Alphamissense ; Missense Variants ; Neuromuscular Disorder ; Next-generation Sequencing; Mutations
ISSN (print) / ISBN
2214-3599
e-ISSN
2214-3602
Quellenangaben
Article Number: 22143602251370957
Publisher
IOS Press
Publishing Place
Amsterdam
Reviewing status
Peer reviewed
Institute(s)
Institute of Neurogenomics (ING)